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TTXNeuronal activity is highly dependent on energy metabolism; yet, the two processes have traditionally been
regarded as independently regulated at the transcriptional level. Recently, we found that the same
transcription factor, nuclear respiratory factor 1 (NRF-1) co-regulates an important energy-generating
enzyme, cytochrome c oxidase, as well as critical subunits of glutamatergic receptors. The present study
tests our hypothesis that the co-regulation extends to the next level of glutamatergic synapses, namely,
neuronal nitric oxide synthase, which generates nitric oxide as a downstream signaling molecule. Using in
silico analysis, electrophoretic mobility shift assay, chromatin immunoprecipitation, promoter mutations,
and NRF-1 silencing, we documented that NRF-1 functionally bound to Nos1, but not Nos2 (inducible) and
Nos3 (endothelial) gene promoters. Both COX and Nos1 transcripts were up-regulated by depolarizing KCl
treatment and down-regulated by TTX-mediated impulse blockade in neurons. However, NRF-1 silencing
blocked the up-regulation of both Nos1 and COX induced by KCl depolarization, and over-expression of
NRF-1 rescued both Nos1 and COX transcripts down-regulated by TTX. These ﬁndings are consistent with
our hypothesis that synaptic neuronal transmission and energy metabolism are tightly coupled at the
molecular level.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Nitric oxide (NO) is a short-lived radical that acts via a second
messenger (cGMP)withmany diverse actions in the nervous, vascular,
and immune systems [1–2]. Nitric oxide synthase (NOS) is responsible
for NO production by catalyzing the conversion of L-arginine to L-
citrulline in an NADPH and calcium/calmodulin-dependent reaction
[3]. NOS constitutes a family of three distinct isoforms: neuronal
(NOS1 or nNOS), inducible (NOS2 or iNOS), and endothelial (NOS3
or eNOS) [3–5]. In many brain areas, NOS1 is activated by the inﬂux of
Ca2+ via glutamatergic NMDA receptors, inducing the binding of
calmodulin and the generation of NO, which functions as a signaling
molecule through the cGMP pathway [6–7]. Excitatory glutamatergic
transmission is highly energy-dependent, asmembrane repolarization
after depolarization requires ATP-dependent Na+/K+ ATPase to
actively pump cations against their concentration and electrical
gradients, whereas repolarization after hyperpolarization is mainly
passive [8]. Thus, neuronal activity, especially of the excitatory type,
and energymetabolism are tightly coupled processes [8]. Regionswith
a higher concentration of glutamatergic synapses than GABAergic1 414 456 6517.
.
l rights reserved.synapses are also rich in cytochrome c oxidase (COX) [9], a critical
energy-generating enzyme that catalyzes the ﬁnal step of oxidative
metabolism [8,10]. When excitatory transmission is suppressed, such
as with TTX-induced impulse blockade, the level of COX as well as of
NMDA receptors and NOS1 are reduced [11–12].
Recently, we found that the coupling between glutamatergic
synapses and oxidative metabolism exists at the transcriptional level.
Essential NMDA receptor subunit 1 as well as subunit 2b and all
subunits of COX are regulated by the same transcription factor, nuclear
respiratory factor 1 (NRF-1) [13–14], a transcription factor known to
be critical for mitochondrial biogenesis [15–16]. As a putative NRF-1
binding site has been reported for human Nos1 gene but not
functionally characterized [17], we sought to determine if NRF-1
indeed directly regulates the expression of Nos1 in murine neurons.
Using multiple approaches, we document in the present study that
NRF-1 functionally regulates the expression ofNos1 in rodent neurons,
but via a site different from the one reported by Hall et al. in humans.
2. Materials and methods
All experiments were carried out in accordance with the US
National Institutes of Health Guide for the care and use of laboratory
animals and the Medical College of Wisconsin regulations. All efforts
were made to minimize the number of animals and their suffering.
Table 1B
Chip primers.
Gene promoter Position Sequence Amplicon
length
Nos1 −134 to +68 F 5′AAACGCAAAGTGGGAGGTCT 3′ 202 bps
R 5′GCATGGCTGGTTTACGTTTT 3′
Nos2 −140 to +5 F 5′AGCTAACTTGCACACCCAACT 3′ 145 bps
R 5′GGGCCAGAGTCTCAGTCTTC 3′
Nos3 −171 to +17 F 5′GGTATTTGATGCTCGGGACT 3′
R 5′CACTGTGATGGCTGAACTGA 3′
188 bps
TFB2M promoter −64 to +115 F 5′GAAGCGAGTGAGCAAAGGAC 3′ 179 bps
R 5′GGTCCCCTCATCCTCCTCTA 3′
β-Actin exon 5 −134 to +53 F 5′GCTCTTTTCCAGCCTTCCTT 3′ 187 bps
R 5′CGGATGTCAACGTCACACTT 3′
Positions of amplicons are given relative to TSP.
1605S.S. Dhar et al. / Biochimica et Biophysica Acta 1793 (2009) 1604–16132.1. Cell culture
Murine neuroblastoma (N2a) cells (ATCC, CCL-131) were grown
in Dulbecco's modiﬁed Eagle's medium supplemented with 10% fetal
bovine serum, 50 U/ml penicillin, and 100 mg/ml streptomycin
(Invitrogen, Carlsbad, CA) at 37 °C in a humidiﬁed atmosphere with
5% CO2.
Sprague Dawley rats (Harlan, Indianapolis, IN) at 1 day of age
were used for primary cultures. Rat primary visual cortical neurons
were cultured as described previously [18]. Brieﬂy, 1-day-old
neonatal rat pups were sacriﬁced by decapitation. Brains were
removed from the skull and the meninges were removed. Visual
cortical tissue was dissected, trypsinized, and triturated to release
individual neurons. Neurons were plated in 35 mm poly-L-lysine-
coated dishes at a density of 50,000 cells/dish. Cells were maintained
in Neurobasal-A media supplemented with B27 (Invitrogen). Ara-C
(Sigma, St. Louis, MO) was added to the media to suppress the
proliferation of glial cells.
2.2. Murine NOS isoform gene promoters analyzed by in silico analysis
DNA sequences surrounding the transcription start points (TSPs)
of NOS isoform genes (Nos1, 2, and 3) were derived from the mouse
genome database in GenBank™ using Genomatix Gene2promoter
software as well as NCBI GenBank. These promoter sequences
encompassed 1 kb upstream and up to 1 kb downstream of the TSP
of each gene analyzed. Computer-assisted search for putative NRF-1
core binding sequences “GCGCA(T/C)GC” or “GCGCA(G/C)GC” was
conducted on each promoter sequence. Alignment of human, mouse,
and rat promoter sequences were done as previously described, using
the Genome VISTA genome alignment tool [13,18]. Mouse Nos1, 2,
and 3 promoter sequences were compared with rat and human
genomic sequences using a 5-bp calculation window. Regions of high
homology and/or containing putative NRF-1 binding sites were
compared for the conservation of NRF-1 binding.
2.3. In vitro interactions via electrophoretic mobility shift (EMSA) and
supershift assays
EMSAs to assay NRF-1 interactions with putative binding
elements on NOS isoform genes were carried out with methods as
previously described [13]. Brieﬂy, oligonucleotide probes with
putative NRF-1 binding site on each promoter (Nos1–3) (Table 1A,
based on in silico analysis) were synthesized. These oligonucleotides
were annealed, and labeled by a Klenow fragment ﬁll-in reaction
with [α-32P] dATP (50 μCi/200 ng). Each labeled probe was incubated
with 2 μg of calf thymus DNA and 5 μg of HeLa nuclear extract
(Promega, Madison, WI) and processed for EMSA. Supershift assays
were also performed and, in each reaction, 1–1.5 μg of NRF-1-speciﬁc
antibodies (polyclonal goat antibodies, gift of Dr. Richard Scarpulla,
Northwestern University, Chicago, IL) were added to the probe/Table 1A
EMSA probes.
Gene promoter Position Sequence
Nos1 +150/+164 F 5′TTTTGTGCCGCGGAGCAGAGCGGCCTT 3′
R 3′ CACGGCGCCTCGTCTCGCCGGAATTTT 5′
Nos2 −98/−73 F 5′TTTTAGTTATGCAAAATAGCTCTGCAGAG 3′
R 3′ TCAATACGTTTTATCGAGACGTCTCTTTT 5′
Nos3 −114/−89 F 5′TTTTCCACATTAAATACGCAACAAATAGA 3′
R 3′ GGTGTAATTTATGCGTTGTTTATCTTTTT 5′
Nos1 with mutated
NRF-1site
−49/−24 F 5′TTTTGTAAAGCGGAAAAGAGCGGCCTT 3′
R 3′ CATTTCGCCTTTTCTCGCCGGAATTTT 5′
Rat Cyt C −172/−147 F 5′TTTTCTGCTAGCCCGCATGCGCGCGCACCTTA 3′
R 3′ GACGATCGGGCGTACGCGCGCGTGGAATTTTT 5′
Positions of probes are given relative toTSP. Putative NRF-1 binding sites are in boldface.
Mutated nucleotide sequences are underlined.nuclear extract mixture and incubated for 20 min at room tempe-
rature. For competition, 100-fold excess of unlabeled oligonucleotides
were incubated with nuclear extract before adding labeled oligonu-
cleotides. Shift reactions were loaded onto 4% polyacrylamide gel and
ran at 200 V for 2.5 h in 0.25× TBE buffer. Results were visualized by
autoradiography. Rat cytochrome c with NRF-1 binding site at posi-
tion−172/−147 was designed as previously described [15] and used
as a positive control. NRF-1 mutants with mutated sequences as
shown in Table 1A were used as negative controls.
2.4. In vivo interactions using chromatin immunoprecipitation (ChIP)
assays
ChIP assays were performed similar to those described previously
[13]. Brieﬂy, ∼750,000 N2a cells were used for each immunopreci-
pitation and were ﬁxed with 1% formaldehyde for 10 min at room
temperature. ChIP assay kit (Upstate, Charlottesville, VA) was used
with minor modiﬁcations. Following formaldehyde ﬁxation, cells
were resuspended in a swelling buffer (5 mM PIPES, pH 8.0, 85 mM
KCl, and 1% Nonidet P-40, and protease inhibitors added right before
use) and homogenized 10 times in small pestle Dounce tissue
homogenizer (7 ml). Nuclei were then isolated by centrifugation
before being subjected to sonication. The sonicated lysate was
immunoprecipitated with either 0.2 μg of NRF-1 polyclonal rabbit
antibodies (gift of Dr. Scarpulla) or 2 μg of anti-nerve growth factor
receptor (NGFR) p75 polyclonal goat antibodies (C20, sc-6188, from
Santa Cruz Biotechnology, Santa Cruz, CA). Semi-quantitative PCR
was performed using 1/20th of precipitated chromatin. Primers
targeting promoter sequences near TSP of Nos1–3 genes were
designed (Table 1B) as previously described [18]. The promoter of
transcription factor B2 of mitochondria (TFB2M), previously found to
be activated by NRF1 [19–20], was used as a positive control, whereas
exon 5 of β-actin gene was used as a negative control (Table 1B). PCR
reactions were carried out with the EX Taq hot-start polymerase
(Takara Mirus Bio, Madison, WI) with the following cycling
parameters: 30-s denaturation at 94 °C, 30-s annealing at 59.5 °C,
and 20-s extension at 72 °C (32–36 cycles per reaction). All reactions
were hot-started by heating to 94 °C for 120 s. Use of hot-start
polymerase and PCR additives signiﬁcantly improved the quality and
reproducibility of ChIP. PCR products were visualized on 2% agarose
gels stained with ethidium bromide.
2.5. Promoter mutagenesis study
Luciferase reporter constructs of Nos1 promoters were made by
PCR cloning the proximal promoter sequences using genomic DNA
prepared frommouse N2a cells as template, digested with HindIII and
KpnI restriction enzymes, and ligated directionally into pGL3 basic
vector (Promega).
Sequences of primers used for PCR cloning and mutagenesis are
provided in Table 1C. Subunit COX6b1 clone was used as previously
Table 1C
PCR cloning primers.
Cloning primers Primer sequence
Nos1 F 5′AAGGTACCGCCAGGTGACCACCACTAAC 3′
R 5′AAAAGCTTCTGACGCATGGCTGGTTTAC 3′
MCOX6b1 F 5′AAGGTACCGCCAGCCCTTAATTGTTTTC 3′
R 5′AAAAGCTTTCGCAACTAAAAGCTCCACA 3′
Mutagenesis
primers
Nos1Mut F 5′ GAGGTGCCGCGGATTTGAGCGTTCTTATCCAAGCC 3′
R 5′ GGCTTGGATAAGAACGCTCAAATCCGCGGCACCTC 3′
MCOX6b1Mut F 5′CAGCACTAGTTAGGCAGAGTTTGGCGGATTTCTGAGTCTAC 3′
R 5′GTAGACTCAGAAATCCGCCAAACTCTGCCTAACTAGTGCTGG 3′
NRF-1 mutated nucleotide sequences are in boldface.
Table 2
Primers for real-time PCR.
Gene Sequence Amplicon
length
Tm
Nos1 F 5′CTGGAGGAAGTAGCCAAGAAG 3′ 154 60°
R 5′TTCTCCATGGTTTGATGAAGG 3′
Nos2 F 5′TGATCTTGTGCTGGAGGTGACCAT 3′ 200 60°
R 5′TGTAGCGCTGTGTGTCACAGAAGT 3′
Nos3 F 5′TATTTGATGCTCGGGACTGCAGGA 3′ 92 60°
R 5′ACGAAGATTGCCTCGGTTTGTTGC 3′
NRF-1 F 5′GGCACAGGCTGAGCTGATG 3′ 90 59.5°
R 5′CTAGTTCCAGGTCAGCCACCTTT 3′
NRF-2α F 5′CTCCCGCTACACCGACTAC 3′ 145 59.5°
R 5′TCTGACCATTGTTTCCTGTTCTG 3′
COX2 F 5′TGGCTTACAAGACGCTACATC 3′ 201 59.5°
R 5′GGAGGGAAGGGCAATTAGAA 3′
COX6c F 5′AGCGTCTGCGGGTTCATA 3′ 154 60°
R 5′GCCTGCCTCATCTCTTCAAA 3′
Gucy1a2 F 5′GTGCATATCCAGCAATGTTGAACGG 3′ 89 60°
R 5′CGTTGCAAACGGTGAATTATCCTGCC 3′
β-Actin F 5′GGCTGTATTCCCTCCATCG 3′ 154 59.5
R 5′CCAGTTGGTAACAATGCCATGT 3′
18S F 5′CGCGGTTCTATTTTGTTGGT 3′ 219 59.5°
R 5′AGTCGGCATCGTTTATGGTC 3′
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site on each promoter was generated using QuikChange site-directed
mutagenesis kit (Stratagene, La Jolla, CA). Both constructs were
veriﬁed by sequencing.
Each promoter construct (Nos1 and COX6b1) was transfected into
N2a cells in a 24-well plate using Lipofectamine 2000. Each well
received 0.6 μg of promoter construct and 0.03 μg of pCMVβgal, which
constitutively expressed β-galactosidase. After 48 h of transfection,
cell lysates were harvested and measured for luciferase activity as
described previously [13].
To further investigate the effect of KCl stimulation after mutating
the NRF-1 binding site, transfected neurons were stimulated with KCl
at a ﬁnal concentration of 20 mM in the culture media for 5 h as
previously described [21]. Cell lysates were then harvested and
measured for luciferase activity as described previously [13].
2.6. NRF-1 shRNA plasmid construction
NRF-1 silencing was carried out using small hairpin RNAs (shRNA)
against murine NRF-1 (GenBank™ accession no. for NRF-1:
NM_010938) cloned into pLVTHM vector with H1 promoter and
green ﬂuorescent protein reporter (gift of Dr. P. Aebischer, Swiss
Federal Institute of Technology). Four shRNA sequenceswere selected:
5′-GAAAGCTGCAAGCCTATCT-3′; 5′-GCCACAGGAGGTTAATTCA-3′; 5′-
GCATTACGGACCATAGTTA-3′; and 5′-AGAGCATGATCCTGGAAGA-3′,
with a linker sequence (5′-TTCAAGAGA-3′) and complementary
sequence for each to form the NRF-1-shRNA cassette. Multiple
shRNA sequences enhance the efﬁciency of gene silencing [22–23].
The pLL3.7/U6 promoter vector with puromycin resistance (Addgene,
Cambridge, MA) vector was used concurrently for puromycin selec-
tion. The empty vector pLVTHMor scrambled shRNA inpLVTHMserved
as negative controls. The basic gene cloning method was followed as
described previously [13,20]. N2a cells or primary neuronswere plated
in 35-mm dishes at a density of 5 to 8×106 cells/dish. They were co-
transfected 3 days post-plating with NRF-1 shRNA expression vectors
(four sequences at equal amounts; 4 μg total for N2a cells and 1 μg total
for primary neurons) and the pLL3.7/U6 vector for puromycin resis-
tance (1.5 μg for N2a cells and 1 μg for primary neurons) via
Lipofectamine 2000. Empty vectors or scrambled shRNA vectors
alone were used at the same concentrations as vectors with shRNA
against NRF-1. Puromycin at a ﬁnal concentration of 0.5 μg/ml was
added to the culture medium on the second day after transfection to
select for purely transfected cells. Green ﬂuorescence was observed to
monitor transfection efﬁciency. Transfection efﬁciency for N2a cells
ranged from 40% to 75%, while that for primary cortical neurons was
from 40% to 60%. However, puromycin selection effectively yielded
100% of transfected cells. Cells were harvested after 48 h of silencing
and lysed for either protein or total RNA preparation.
To determine the effect of KCl stimulation, N2a cells transfected
with shRNA against NRF-1 were exposed to KCl at a ﬁnal concentra-
tion of 20mM in the culturemedia for 5 h as previously described [21].
Cells were then harvested for RNA isolation.2.7. RNA isolation and cDNA synthesis
Total RNA was isolated by RNeasy kits (Qiagen, Valencia, CA)
according to the manufacturer's instructions. Three micrograms of
total RNA was treated with DNase I and puriﬁed by phenol-chloro-
form. cDNA was synthesized using random hexamer primers and
SuperScript™ II RNase H-Reverse Transcriptase (Invitrogen) according
to the manufacturer's instructions.
2.8. Real-time quantitative PCR
Real-time quantitative PCRs were carried out in a Cepheid Smart
Cycler Detection system (Cepheid, Sunnyvale, CA). SyBr Green
(BioWhittaker Molecular Application) and EX Taq real-time quanti-
tative PCR hot-start polymerase were used following the manufac-
turer's protocols and as described previously [13]. Primer sequences
are shown in Table 2. PCR runs: hot-start 2 min at 95 °C, denaturation
10 s at 95 °C, annealing 15 s according to the Tm of each primer, and
extension 10 s at 72 °C for 15–30 cycles. Melt curve analyses veriﬁed
the formation of single desired PCR product. Mouse β-actin for N2a
cells and rat 18s for primary neurons was used as the internal control
and the 2-ΔΔCT method [24] was used for the relative amount of
transcripts. Subunits COX2 (mitochondrial-encoded) and COX6c
(nuclear-encoded) were used as previously described [13].
2.9. Western blot assays
Control and NRF-1 shRNA samples were lysed with lysis buffer
(0.5% Triton-X-100 and 5 mM ethylenediamine-tetraacetic acid
(EDTA) in PBS with 1×complete protease inhibitor) and centrifuged.
The concentration of the supernatant was measured with the Bio-Rad
protein Assay Kit II (Bio-Rad, Hercules, CA, USA). A total of 50 μg
proteins were loaded onto each lane of 10% SDS-PAGE gels and
electrophoretically transferred onto polyvinylidene diﬂuoride mem-
branes (Bio-Rad, Hercules, CA). Subsequent to blocking, blots were
incubated in primary antibodies (polyclonal antibodies against NRF-1
(1:500; gift of Dr. Scarpulla)), NOS1 (monoclonal antibodies, 1:200;
N2280, Sigma), or NOS2 (1:200; sc-7271, C11 from Santa Cruz
Biotechnology). Monoclonal antibodies against β-actin (A5316,
Sigma) at 1:3000 dilutions were used as loading controls. Blots
were then incubated in secondary antibodies (goat-anti-rabbit, goat-
anti-mouse, or rabbit-anti-goat; Chemicon), reacted with ECL, and
exposed to autoradiographic ﬁlm (Santa Cruz Biotechnology).
Fig. 1. NRF-1 interactions in vitro and in vivo with NOS isoform genes and promoter
mutational analysis. EMSAs for NRF-1. 32P-labeled oligonucleotides, excess unlabeled
oligos as competitors, excess unlabeled mutant NRF-1 as competitors, HeLa extract,
and NRF-1 antibodies are indicated by a + or a − sign. Arrowheads indicate NRF-1
shift and supershift complexes. The positive control, cytochrome c, shows a shift (A,
lane 1) and a supershift (A, lane 3) band. When excess unlabeled competitor was
added, it did not yield any band (A, lane 2). Nos1 subunit showed speciﬁc shift and
supershift bands that were eliminated by excess unlabeled competitors (A, lanes 5, 8
and 6, respectively), while Nos2 and Nos3 showed no shift bands (A, lanes 12–13).
Labeled mutated NRF-1 site on Nos1 was used as a negative control, and it did not
yield any band (A, lanes 9–11). Excess unlabeled but mutated NRF-1 site could not
compete (A, lane 7). Labeled oligos with NRF-1 antibodies alone with no HeLa extract
did not yield any band (A, lane 4).
1607S.S. Dhar et al. / Biochimica et Biophysica Acta 1793 (2009) 1604–1613Quantitative analyses of relative changes were done with Personal
Molecular Imager, with Quantity one 1-D analysis software (Bio-Rad).
2.10. NRF-1 over-expression and TTX treatment
pSG5NRF-1 expression plasmid, a generous gift from Dr. Richard
Scarpulla [25], was used for NRF-1 over-expression. N2a cells and
primary neurons were each plated in 35 mm dish at a density of 2 to
5×105 cells/dish. N2a cells were co-transfected 3 days post-plating
with either 2.5 μg of the pSG5NRF-1 plasmid or an empty vector plus
0.5 μg of pLL3.7 Puro vector, using Lipofectamine 2000 (Invitrogen) at
a 1:3 ratio. Procedures were identical for the transfection of primary
neurons, except that 2 μg pSG5NRF-1 plasmids were used. Puromycin
at a ﬁnal concentration of 0.5 μg/ml was added on the second day after
transfection to select for purely transfected cells. After 1 day of over-
expression, TTX at a ﬁnal concentration of 0.4 μM was added to the
culture media for 3 days. N2a cells and primary neurons were
harvested on the 4th day for RNA isolation.
2.11. Statistical analysis
Signiﬁcance among group means was determined by analysis of
variance (ANOVA). Signiﬁcance between two groups was analyzed
by Student's t-test. P values of 0.05 or less were considered
signiﬁcant.
3. Results
3.1. Promoter analysis of NOS genes by means of in silico analysis
The proximal promoters of murine Nos1, 2, and 3 genes were
analyzed using in silico analysis with DNA sequence 1 kb 5′ upstream
and 1 kb beyond 3′ of transcription start point (TSP). The sequence
(GCGCGTGTGCGC) reported but not functionally characterized by Hall
et al. [17] to be the putative NRF-1 binding site in the humanNos1 gene
has no homology in either the mouse or rat Nos1 gene; thus we were
not able to use it for the present study. Moreover, it lacks a GCA core
found by us to be invariant for NRF-1 binding in the genes thatwe have
analyzed thus far in neurons [13,14,26] and is present in the traditional
NRF-1 sequence [15]. In searching further for putative NRF-1 binding
site even 2 kb upstream and downstream of TSP, we could ﬁnd only a
single site with GC-rich sequences ﬂanking a GCA core (GCGAGCA-
GAGCGGCGC) in exon 1 coding region of murineNos1 gene designated
by Genomatix as a promoter region (Gene ID 18125, Genomatix
GXP_435815, NCBI NT_078458, and ENSMUST00000102557). It bore a
high (85–95%) homology with both the rat and human Nos1 genes
(Table 3). This region was also rich in putative binding sites for other
transcription factors, such as NRF-2, Sp1, and CREB (unpublished
observations).
At least twelve alternative exon 1 have been identiﬁed in the
human Nos1 gene, and transcription is partially controlled by exonTable 3
Aligned partial sequences of Nos1 promoters from rat (R), mouse (M), and human (H)
genomes show conservation of NRF-1 binding sites (in boldface).
Invariant GCA core sequences are underlined. Solid boxes highlight NRF-1 sites that are
highly conserved in all three or at least two species.1-speciﬁc promoter sequences [27,28]. In mice, ﬁve alternatively
spliced variants and one unspliced form encoding ﬁve different
isoforms of protein have been reported, and our NRF-1 core binding
sequence matched two of the splice variants, aSep07Nos1 and
bSep07Nos1, found also in vivo [29]. This diversity of alternative
promoters and Nos1 transcripts probably helps to control the
diversity of Nos1 expression in many different organs [27].
Transcriptional regulatory element has been found in the coding
sequence in a number of genes [30–32].
Nos2 and Nos3 promoters, on the other hand, lack both typical and
atypical NRF-1 binding sites. Thus, we selected from a region close to
the TSP with some GC and a GCA sequences for each of the genes as
probes for electrophoretic mobility shift assays.
3.2. In vitro NRF-1 interactions with NOS promoters
Electrophoretic mobility shift assays (EMSAs) for NRF-1 interac-
tions were carried out in vitro using 32P-labeled oligonucleotide
probes to determine the speciﬁcity of NRF-1 binding to murine NOS
promoters (Nos1, Nos2 and Nos3) (Fig. 1). Rat cytochrome c promoter
with known NRF-1 site at positions −172/−147 [15] served as a
positive control and it formed speciﬁc DNA/NRF-1 shift and super-
shift complexes (Fig. 1, lanes 1 and 3, respectively). When an excess
of unlabeled probe was added as a competitor, no shift band was
formed (Fig. 1, lane 2). Nos1 promoter formed a speciﬁc DNA–
protein shift complex when incubated with HeLa nuclear extract
(Fig. 1, lane 5) and a DNA–protein–antibody supershift complex with
the addition of NRF-1 antibodies (Fig. 1, lane 8). Competition with
excess unlabeled probe eliminated the shift complex (Fig. 1, lanes 6
and l0, respectively), whereas an excess of unlabeled mutant NRF-1
probes was not able to compete (Fig. 1, lane 7). To rule out any non-
speciﬁc antibody and oligonucleotide interaction, labeled probes
were incubated with NRF-1 antibody without HeLa nuclear extract,
and no shift bands were observed (Fig. 1, lane 4). Nos1 probe with
Fig. 3. Site-directed mutations of NRF-1 binding sites on Nos1 and COX6b1 promoters.
Mutated NRF-1 binding sites on Nos1 and COX6b1 subunits resulted in signiﬁcant
reductions in luciferase activity as compared to wild type (wt). (N=6 for each
construct). ⁎, Pb0.05, ⁎⁎⁎, Pb0.001.
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(Fig. 1, lanes 9 and 11, respectively). Nos2 and Nos3 lacked both
typical and atypical NRF-1 binding sites and did not yield any shift
bands (Fig. 1, lanes 12–13), verifying our previous report that the
presence of a GCA core ﬂanked by GC-rich sequences are essential
for NRF-1 binding in neurons [13–14,26].
3.3. In vivo interaction of NRF-1 with NOS isoform genes
To verify NRF-1 interactions with NOS isoform genes in vivo,
chromatin immunoprecipitation assays (ChIP) were performed.
PCRs that targeted NOS isoform promoters surrounding putative
NRF-1 binding sites were carried out in parallel on chromatin
immunoprecipitated from N2a cells. A 0.5 and 0.1 % dilution of input
chromatin (i.e. prior to immunoprecipitation) was used as a
standard to indicate the efﬁciency of the PCRs. The proximal pro-
moters of Nos1–3 isoforms in the presence of nuclear extract were
subjected to chromatin immunoprecipitation with NRF-1 antibodies.
Nos1 and TFB2M each produced a band from DNA immunoprecipi-
tated with anti-NRF-1 antibodies at a position identical to that of
the genomic DNA control (input) (Fig. 2). On the other hand, Nos2,
Nos3 and β-actin yielded no bands (Fig. 2). In all cases, immuno-
precipitation with NGFR antibodies, an additional negative control,
did not yield any PCR product, conﬁrming the speciﬁcity of the ChIP
reaction.
3.4. Mutational analysis for Nos1 and COX6b1 promoters
Based on EMSA probes (Table 1A) that formed NRF-1 speciﬁc
complexes (Fig. 1), site-directed mutagenesis of these same
putative NRF-1 binding sites on Nos1 and known murine COX6b1
[13] promoters were constructed (Table 1C), generated in luciferase
reporter plasmids, and analyzed by gene transfection. As shown in
Fig. 3, mutation of NRF-1 binding sites led to ∼61–66% reduction in
promoter activity of Nos1 and COX6b1 genes, respectively (Pb0.05–
0.001). COX6b1 subunit promoter served as a positive control and
conﬁrmed our previous report [13].
3.5. Knockdown of NRF-1 by RNA interference
To determine the effect of NRF-1 knockdown on the expression of
NOS, plasmid vectors expressing small hairpin RNA (shRNA) against
target sequences of NRF-1 mRNA were used. These vectors were
previously found to suppress NRF-1 expression in N2a cells [13].
Transfection of neurons with shRNA vectors resulted in ∼70–85%
decrease in levels of NRF-1 and NOS1, but not of NOS2, proteins asFig. 2. ChIP assays. Input lanes represent 0.5% and 0.1% of chromatin. TFB2M promot
immunoprecipitated with NRF-1, while Nos2 and Nos3 did not. Anti-nerve growth factor remeasured by western blots (Pb0.05–0.01) (Fig. 4A). cDNAs from N2a
cells (Fig. 4B) and primary neurons (Fig. 4C) transfected with NRF-1
shRNA vectors, scrambled shRNA vectors, or empty vectors were
analyzed with quantitative real-time PCRs. As shown in Fig. 4B and C,
relative mRNA levels of NRF-1, Nos1, and two positive controls (COX2
and COX6c) were signiﬁcantly reduced in both N2a cells and primary
neurons transfected with shRNA as compared to those transfected
with empty vectors. The extent of reduction ranged between 70 and
85% (Pb0.01–0.001). On the other hand, the expression of Nos2, Nos3,
and nuclear respiratory factor 2α (another transcription factor)
remained unchanged. The normal levels of Nos2 and Nos3 mRNA in
both N2a cells and primary neurons were ∼14–30% and 25–50%,
respectively, as compared to that of Nos1 (data not shown). The
scrambled shRNA also did not have any effect on any mRNA level
tested (Fig. 4B, C).
3.6. Response of Nos1 gene promoter to KCl depolarizing stimulation
To determine if depolarizing stimulation altered the expression
of Nos1 gene in N2a cells, 20 mM of potassium chloride was added
to the culture media for 5 h, a mild regimen previously found to
activate NRF-1 and COX gene expression in primary neurons
[21,33–34]. As shown in Fig. 5A for N2a cells, depolarizing
stimulation resulted in a signiﬁcant increase (∼120%) in the activity
of Nos1 promoter as monitored by luciferase assays (Pb0.05–0.01).
This increase was abolished by mutating the NRF-1 site, conﬁrming
a link between KCl-induced depolarization and the activation of
Nos1 via NRF-1 binding.er was the positive control and β-actin was the negative control. Nos1 promoter
ceptor p75 antibodies (NGFR) represent a negative control.
Fig. 4. NRF-1 silencing suppresses Nos1 and COX subunit mRNAs. (A) Western blot reveals a down-regulation of NRF-1 and NOS1 protein levels in NRF-1 shRNA-transfected neuron,
whereas NOS2 protein levels were not affected. β-Actin served as a loading control. (B, C) N2a cells and primary neurons were transfected with shRNA against NRF-1 (light gray bars),
or with empty vectors (black bars), or with scrambled shRNA (dark gray bars). NRF-2α served as a negative control. NRF-1, Nos1, COX2, and COX6c subunit mRNAs show signiﬁcant
decreases in shRNA-treated samples as compared to those with empty vectors, whereas Nos2, Nos3, and NRF-2αmRNA remained unchanged. N=6 for each data point. ⁎, Pb0.05; ⁎⁎,
Pb0.01 as compared to empty vectors.
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To determine if NRF-1 silencing affected the expression of NOS and
COX subunit genes, N2a cells were transfected with NRF-1 shRNA for
48 h and then subjected to 20 mM of KCl for 5 h. As shown in Fig. 5B,
depolarizing stimulation resulted in a 185% to 198% increase in the
expression of Nos1, COX2, and COX6c genes as monitored by real-time
quantitative PCR (Pb0.05–0.01) without affecting the expression of
Nos2 and Nos3. In the presence of NRF-1 silencing, however, KCl
depolarization could no longer up-regulate themessage levels of Nos1,
COX2, and COX6c. These results conﬁrmed the essential role of NRF-1
in the regulation of Nos1 and COX subunits in response to changing
neuronal activity.
3.8. NRF-1 over-expression increased Nos and COX subunit mRNA levels
and rescued neurons from tetrodotoxin-induced transcript reduction
A low concentration of TTX (0.4 μM) has been shown to decrease
levels of COX subunit mRNAs as well as COX enzyme activity in vivo
and in primary neurons [11,34]. To determine if over-expression ofNRF-1 could rescue not only COX but also Nos1 transcript, a pSG5NRF-
1 construct (gift of Dr. Richard Scarpulla) for NRF-1 over-expression
was transfected into primary neurons that were then exposed to TTX
(0.4 μM) for 3 days. When neurons were transfected with empty
vectors, exposure to TTX led to a 52% reduction in NRF-1 and a 71–75%
reduction in Nos1, Nos2, Nos3, COX2, and COX6C mRNA levels (Fig.
6A–F), indicating an overall suppressive effect of TTX on gene
expression in neurons. Neurons transfected with the pSG5NRF-1
construct had a 600% increase in mRNA levels of NRF-1 (Pb0.001)
(Fig. 6A) and a 64–78% increase in those of Nos1, COX2, and COX6C
(Pb0.05–0.01) as compared to empty vector controls (Fig. 6B–D). No
change in Nos2 and Nos3 levels was evident (Fig. 6E–F). When
exposed to TTX, neurons transfected with pSG5NRF-1 expressed 45–
57% more Nos1, COX2, and COX6C transcripts as compared to those
with empty vectors (Pb0.05–0.01) (Fig. 6A–D). No increase was found
for Nos2 and Nos3 (Fig. 6E–F). The expression of NRF-1 itself was 286%
higher in pSG5NRF-1-transfected neurons than those with empty
vectors in the presence of TTX (Pb0.001) and 234% higher in the
absence of TTX (Pb0.001). These results conﬁrmed that NRF-1 could
rescue Nos1 and COX subunit mRNAs but not those of Nos2 and Nos3
in the presence of TTX.
Fig. 5. Depolarization-induced up-regulation of promoter gene expression and mRNA
levels of NOS and COX subunits in neurons. (A) Site-directed mutations of NRF-1
binding sites on Nos1 promoter resulted in a signiﬁcant reduction in luciferase activity
as compared to thewild type (wt). KCl depolarization increased promoter activity in the
wild type but not in the mutated Nos1. (N=6 for each construct). ⁎, Pb0.05, ⁎⁎, Pb0.01
as compared to Nos1 wild type. X=Pb0.01 as compared to Nos1 wt with KCl depola-
rization. (B) Data from real-time quantitative PCR indicate that Nos1, COX2, and COX6c
gene expression in N2a cells were increased by KCl depolarization as compared to
controls, whereas those of Nos2 and Nos3were not affected by KCl. NRF-1 silencing with
shRNA prevented the up-regulation of Nos1, COX2, and COX6c mRNAs by KCl. Again,
Nos2 and Nos3 were not affected. Values represent mean±S.E.M. of combined data
from 3 independent experiments. ⁎Pb0.05, ⁎⁎Pb0.01 versus controls. All #P values were
compared to 20 mM KCl-treated samples (#Pb0.05). Nos2 and Nos3 levels were not
signiﬁcantly different from controls.
1610 S.S. Dhar et al. / Biochimica et Biophysica Acta 1793 (2009) 1604–16133.9. Effect of NRF-1 silencing on guanylyl cyclase activity
To determine if NRF-1 also played an important role in regu-
lating guanylyl cyclase, a downstream target of NO pathway, the
promoter region of soluble guanylyl cyclase gene (Gucy1a2) was
analyzed in silico, and a potential NRF-1 binding was found.
shRNA knockdown of NRF-1 resulted in an 80% decrease in the
expression of Gucy1a2 as compared to empty vector controls
(Pb0.01) (Fig. 7). Scrambled shRNA had no effect. Future studies
will determine if NRF-1 regulates Gucy1a2 directly or indirectly.
4. Discussion
The present study documents with multiple approaches that NRF-
1 co-regulates COX and Nos1, but not Nos2 and Nos3 genes, thereby
linking glutamatergic NOS-mediated synaptic transmission and
energy metabolism at the transcriptional level of regulation in
neurons. There is high homology in NRF-1 binding sites for Nos1
(Table 3) and COX subunit promoters [13] among mice, rats, and
humans, emphasizing the conservation of such co-regulation through
evolution. With depolarizing neuronal activity, NRF-1 itself is
activated at both protein and mRNA levels [21, the present study],
and it, in turn, synchronizes the transcriptional activation of both Nos1
and COX subunit genes, thereby ensuring that neuronal activity and
energy metabolism remain tightly coupled.NOS enzymes constitute a family of proteins with varying func-
tions [35]. NOS1 is neuronal and is present at low concentrations in
many cells but at high concentrations in a select group of neurons,
primarily GABAergic ones [36–37]. NOS2 is typically not present in
unstimulated cells, but is expressed in response to cytokines,
lipopolysaccharides, and immunological challenges in macrophages
[38–40]. NOS3 is expressed mainly in vascular endothelial cells and
plays an important role in the regulation of vascular tone and tissue
perfusion [39–41]. NRF-1 functionally binds to Nos1 but not Nos2 and
Nos3 promoters in neurons, and NRF-1 silencing down-regulates
both protein and mRNA expression of COX and NOS1 without
affecting NOS2 and NOS3 [the present study]. Thus, NRF-1's
regulation of Nos1 is linked to neuronal functioning and not to the
production of NO per se. It also suggests that the transcriptional
regulation of Nos1 is very different from those of Nos2 and Nos3.
Each isoform, in turn, mediates different cellular functions, including
the regulation of various gene expressions [35]. A fourth type of NOS
is reportedly present in the mitochondria [42]. However, NO-
dependent mitochondrial biogenesis in the murine subcortex is
mediated by the NOS1 isoform [43]. Moreover, cardiomyocytes from
neuronal NOS-knockout mice do not produce NO in the mitochon-
dria, unlike those of the wild type, conﬁrming that the mitochondrial
NOS (mtNOS) is actually a neuronal NOS [44]. MtNOS is reportedly
involved in the regulation of oxidative phosphorylation, as NO can
react with COX [42]. However, recent reports indicate that NO
produced in the mitochondria by mtNOS (NOS1) in fact protects COX
from external inhibitors [6,45]. The current study conﬁrms the rela-
tion between COX and NOS1, and not with NOS2 and NOS3.
The level of COX activity in the normal monkey retina, monkey
visual cortex, and cultured rat primary neurons are positively
correlated with the density of distribution of excitatory neurotrans-
mitters and their receptors, such as glutamate, NMDA receptor
subunit NR1, and NOS1 [11–12,46–49]. This is consistent with the
fact that repolarization after excitation-induced depolarization is
highly energy-dependent and consumes the bulk of ATP produced in
the CNS [8]. However, when neuronal activity is altered, such as
afferent impulse blockade by TTX or depolarizing treatment with
KCl, neuronal COX activity is adjusted to match the new energy
demand [8,11]. NOS1 expression is also regulated by changes in
neuronal activity [37,50]. At the transcriptional level, this regulation
involves NRF-1 (present study). Thus, KCl-mediated depolarization
increases neuronal activity and up-regulates both Nos1 and COX
transcripts, but NRF-1 silencing with RNA interference prevented the
up-regulation of Nos1 and COX in the presence of KCl stimulation.
The up-regulation of Nos1 could be limited, as excess production of
NO may induce glutamate toxicity [7]. On the other hand, TTX-
mediated impulse blockade down-regulates both Nos1 and COX
transcripts, and over-expression of NRF-1 is able to rescue both Nos1
and COX mRNAs from the suppressive effect of TTX. These results
conﬁrm the signiﬁcant role of NRF-1 in regulating both Nos1 and
COX gene expression in neurons [13, the present study].
NRF-1, a phosphoprotein, is a transcriptional activator of nuclear
genes encoding a number of mitochondrial respiratory enzymes,
including subunits of the ﬁve respiratory chain complexes [51–52].
In fact, all ten nuclear-encoded subunit genes of complex IV (COX)
are regulated by NRF-1 in neurons [13]. NRF-1 also activates the
promoters of mitochondrial transcription factor A (Tfam), transcrip-
tion speciﬁcity factors (TFB1M and TFB2M), and RNA-processing
proteins required for mtDNA transcription and replication [16,19].
Thus, NRF-1 indirectly regulates the expression of the largest 3 COX
subunit genes encoded in the mtDNA, and effectively regulates all 13
COX subunits. NRF-1 is vital for normal cell growth, cell function,
and mitochondrial biogenesis [51–52], and its knockout is embry-
onically lethal [53]. Based on the present and our previous studies
[13–14,26], the traditional consensus sequence for NRF-1 binding
(YGCGCAYGCGCR) needs to be modiﬁed to include an invariant GCA
Fig. 6. NRF-1 over-expression in primary neurons signiﬁcantly increased mRNA levels for Nos1, COX2, and COX6c genes and rescued them from TTX-induced suppression. NRF-1,
Nos1, COX2, COX6c, Nos2, and Nos3mRNA levels (A–F) were all reduced by TTX as compared to controls. Over-expression of NRF-1 signiﬁcantly increased transcript levels of NRF-1,
Nos1, COX2, and COX6c, but not of Nos2 and Nos3. Over-expression of NRF-1 was able to rescue NRF-1, Nos1, COX2, and COX6c, but not Nos2 and Nos3. Group means were analyzed for
overall statistical signiﬁcance using the Student's t-test (N=6 for each group). All ⁎P values were compared to empty vectors (⁎Pb0.05, ⁎⁎Pb0.01, ⁎⁎⁎Pb0.001). All #P values were
compared to empty vector+TTX (#Pb0.05, ##Pb0.01, ###Pb0.001), and all XP values were compared to NRF-1 over-expression (XPb0.05, XXXPb0.001).
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sequence of GC being variable, especially in rodents.
In response to glutamate, NOS1 is activated by the inﬂux of calcium
via NMDA receptors, and NO is produced to stimulate guanylyl cyclase
to convert GTP to cGMP, an important second messenger that
mediates neurotransmission [3–4,7]. The fact that NRF-1 regulates
critical subunit genes of NMDA receptors [14], NOS1 (present study),Fig. 7. NRF-1 silencing suppresses mRNA level in guanylyl cyclase gene. N2a cells were
transfected with shRNA against NRF-1, or with empty vector, or with scrambled shRNA.
Guanylyl cyclase (Gucy1a2) mRNA shows signiﬁcant decrease in shRNA-treated
samples as compared to those with empty vectors. N=6 for each data point.
⁎, Pb0.01. Scrambled shRNA did not cause any change in Gucy1a2 levels.and possibly guanylyl cyclase via either direct or indirect pathway
(present study) strongly indicate that NRF-1 is intimately associated
with the coordinated regulation of key neurochemicals associated
with a major glutamatergic synaptic pathway in neurons (Fig. 8).
In conclusion, our ﬁndings conﬁrm the tight coupling between
neuronal activity and energy metabolism beyond the cellular level [8]
to the molecular level. By having the same transcription factor
participate in the regulation of both processes, this tight coupling can
be initiated and/or maintained at the transcriptional level. NRF-1 can
effectively coordinate the expression of both Nos1 and COX subunit
genes, thereby coordinating a controlled and stable interplay between
energy utilization of synaptic transmission and energy production.
These ﬁndings beg many other questions. For example, do other
transcription factors participate in the co-regulation of Nos1 and COX?
AP1, Sp1, CREB or NF-kB binding sites have been reported for Nos1
promoters in humans and rats [17,54], but they have not been
functionally characterized in neurons. Their roles in regulating energy
metabolism, if present, have not been deﬁned. Other likely candidates
for co-regulation are nuclear respiratory factor 2 (NRF-2) and the
coactivator peroxisome proliferator-activated receptor-γ coactivator
1α (PGC-1α). Previously, we have shown that NRF-2 also regulates all
13 COX subunits from the two genomes [18,20]. NRF-2 binding sites
Fig. 8. Schematic representation of Nos1 regulation via NRF-1. A working model
indicating that energy metabolism and neuronal activity are tightly coupled. NMDAR
(NR1 and NR2B) [26], COX subunits [13] and Nos1 (present study) are all co-
regulated by the same transcription factor, NRF-1. A downstream mediator of NOS1
pathway, guanylyl cyclase, also has a potential NRF-1 binding site. Thus, NRF-1 is
intimately associated with the coordinated regulation of energy metabolism as well
as key neurochemicals associated with a major glutamatergic synaptic pathway in
neurons.
1612 S.S. Dhar et al. / Biochimica et Biophysica Acta 1793 (2009) 1604–1613appear to be present on the murine Nos1 promoter (our unpublished
observations). PGC-1α is known to stimulate a powerful induction of
both NRF-1 and NRF-2 [55] as well as binds to and co-activates NRF-1
in stimulating Tfam expression [20]. In primary neurons, PGC-1α
responds to changing neuronal activity earlier than those of NRF-1
and NRF-2 [33,56]. Thus, for co-regulating neuronal activity and
energy metabolism, the transcriptional mechanism is likely to engage
many, if not all, of these key factors. Research is underway to explore
these possibilities.
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